JP2024519715A5 - - Google Patents
Info
- Publication number
- JP2024519715A5 JP2024519715A5 JP2023567914A JP2023567914A JP2024519715A5 JP 2024519715 A5 JP2024519715 A5 JP 2024519715A5 JP 2023567914 A JP2023567914 A JP 2023567914A JP 2023567914 A JP2023567914 A JP 2023567914A JP 2024519715 A5 JP2024519715 A5 JP 2024519715A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- lipid
- lipid composition
- composition according
- conjugate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163184584P | 2021-05-05 | 2021-05-05 | |
| US63/184,584 | 2021-05-05 | ||
| PCT/US2022/027926 WO2022235972A1 (en) | 2021-05-05 | 2022-05-05 | Lipid compositions comprising peptide-lipid conjugates |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024519715A JP2024519715A (ja) | 2024-05-21 |
| JP2024519715A5 true JP2024519715A5 (cg-RX-API-DMAC10.html) | 2025-11-18 |
Family
ID=83932960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023567914A Pending JP2024519715A (ja) | 2021-05-05 | 2022-05-05 | ペプチド-脂質コンジュゲートを含む脂質組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220370624A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4334455A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024519715A (cg-RX-API-DMAC10.html) |
| CN (1) | CN118251497A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022270683A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3219053A1 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022235972A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ310613B6 (cs) | 2020-09-23 | 2026-01-28 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CN117098541A (zh) | 2020-11-25 | 2023-11-21 | 阿卡格拉医药公司 | 用于递送核酸的脂质纳米粒及相关使用方法 |
| WO2022235923A2 (en) * | 2021-05-05 | 2022-11-10 | Arcturus Therapeutics, Inc. | Peptide-lipid conjugates |
| CZ310443B6 (cs) | 2021-07-19 | 2025-06-25 | Ústav organické chemie a biochemie AV ČR, v. v. i. | Cyklohexanové lipidoidy pro transfekci nukleových kyselin a jejich použití |
| CN116396178A (zh) * | 2023-01-05 | 2023-07-07 | 北京悦康科创医药科技股份有限公司 | 用于递送核酸的可电离阳离子脂质化合物和组合物及用途 |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
| WO2024244304A1 (zh) * | 2023-06-02 | 2024-12-05 | 康希诺生物股份公司 | 核酸-脂质纳米颗粒组合物、及其冻干制剂、制备方法和应用 |
| WO2025042900A1 (en) * | 2023-08-21 | 2025-02-27 | Washington State University | Messenger rna treatment for succinic semialdehyde dehydrogenase deficiency |
| WO2025117732A1 (en) * | 2023-11-29 | 2025-06-05 | Akagera Medicines, Inc. | Lipid nanoparticles for delivery of nucleic acids and methods of use thereof |
| AU2025217182A1 (en) | 2024-02-02 | 2026-08-06 | Editas Medicine, Inc. | MODIFIED GUIDE RNAs |
| WO2025213138A1 (en) | 2024-04-05 | 2025-10-09 | Editas Medicine, Inc. | Crispr/rna-guided nuclease related methods and compositions for treating primary open angle glaucoma |
| WO2026102260A1 (en) | 2024-11-08 | 2026-05-15 | Editas Medicine, Inc. | Crispr-related methods and compositions targeting angiopoietin like 3 (angptl3) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6051429A (en) * | 1995-06-07 | 2000-04-18 | Life Technologies, Inc. | Peptide-enhanced cationic lipid transfections |
| PT2275551E (pt) * | 1999-10-29 | 2015-06-29 | Novartis Vaccines & Diagnostic | Péptidos antigénicos de neisseria |
| US20090220587A1 (en) * | 2005-02-01 | 2009-09-03 | United State Army | Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| KR101031049B1 (ko) * | 2008-04-17 | 2011-04-25 | 한국생명공학연구원 | 다기능성 퍼플루오르카본 나노 에멀젼을 이용한 세포 표지및 영상화 |
| US8455455B1 (en) * | 2010-03-31 | 2013-06-04 | Protiva Biotherapeutics, Inc. | Compositions and methods for silencing genes involved in hemorrhagic fever |
| EP3643306A3 (en) * | 2011-08-12 | 2020-08-26 | Ascendis Pharma A/S | Carrier-linked prodrugs having reversible carboxylic ester linkages |
| US9833518B2 (en) * | 2012-04-13 | 2017-12-05 | Case Western Reserve University | Heteromultivalent particle compositions |
| EP2950785A4 (en) * | 2013-02-04 | 2016-09-21 | Univ Notre Dame Du Lac | NANOPARTICLE-drug delivery systems |
| CN110003066B (zh) * | 2013-11-18 | 2021-09-03 | 阿克丘勒斯治疗公司 | 用于rna递送的可电离的阳离子脂质 |
| HUE052977T2 (hu) * | 2014-04-22 | 2021-06-28 | Txp Pharma Gmbh | Elágazó szénláncú aminosav-próbával rendelkezõ peptid analóg(ok) |
| WO2016197133A1 (en) * | 2015-06-04 | 2016-12-08 | Protiva Biotherapeutics, Inc. | Delivering crispr therapeutics with lipid nanoparticles |
| CN112367974A (zh) * | 2018-05-15 | 2021-02-12 | DNALite治疗学公司 | 粘液穿透肽、递送媒介和治疗方法 |
-
2022
- 2022-05-05 US US17/737,884 patent/US20220370624A1/en active Pending
- 2022-05-05 CN CN202280044061.0A patent/CN118251497A/zh active Pending
- 2022-05-05 AU AU2022270683A patent/AU2022270683A1/en active Pending
- 2022-05-05 EP EP22799626.1A patent/EP4334455A4/en active Pending
- 2022-05-05 WO PCT/US2022/027926 patent/WO2022235972A1/en not_active Ceased
- 2022-05-05 CA CA3219053A patent/CA3219053A1/en active Pending
- 2022-05-05 JP JP2023567914A patent/JP2024519715A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250145577A1 (en) | Stereochemically enriched compositions for delivery of nucleic acids | |
| US11938227B2 (en) | Lipid nanoparticles encapsulation of large RNA | |
| US20220370624A1 (en) | Lipid compositions comprising peptide-lipid conjugates | |
| US10626393B2 (en) | Delivering CRISPR therapeutics with lipid nanoparticles | |
| AU2021325945A1 (en) | Method of lyophilizing lipid nanoparticles | |
| US9415109B2 (en) | Stable non-aggregating nucleic acid lipid particle formulations | |
| US20210047640A1 (en) | Compositions and methods for treating hypertriglyceridemia | |
| WO2016197132A1 (en) | Treating hepatitis b virus infection using crispr | |
| JP2019218349A5 (cg-RX-API-DMAC10.html) | ||
| Pinheiro et al. | Amino acid-based surfactants for biomedical applications | |
| CA2963271A1 (en) | Compositions and methods for silencing hepatitis b virus gene expression | |
| WO2017019891A2 (en) | Compositions and methods for silencing hepatitis b virus gene expression | |
| JP2011507534A5 (cg-RX-API-DMAC10.html) | ||
| WO2015011633A1 (en) | Compositions and methods for delivering messenger rna | |
| WO2016183366A2 (en) | Compositions and methods for silencing expression of hepatitis d virus rna | |
| US20240300891A1 (en) | Ionizable lipids, lipid nanoparticles for mrna delivery and methods of making the same | |
| JP2024513048A5 (cg-RX-API-DMAC10.html) | ||
| JP6993359B2 (ja) | 生物学的活性物質の細胞への送達のための脂質および複合体 | |
| WO2023218420A1 (en) | Mrna compositions for inducing latent hiv-1 reversal | |
| WO2025101976A1 (en) | Chimeric yeast extracellular vesicles for the enhanced delivery of therapeutic molecules to cells |